17β-estradiol eye drops protect the retinal ganglion cell layer and preserve visual function in an in vivo model of glaucoma.
about
Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future PerspectivesAge at natural menopause genetic risk score in relation to age at natural menopause and primary open-angle glaucoma in a US-based sampleRetinal ganglion cell neuroprotection induced by activation of alpha7 nicotinic acetylcholine receptors.Plate reader-based cell viability assays for glioprotection using primary rat optic nerve head astrocytesGenipin Derivatives Protect RGC-5 from Sodium Nitroprusside-Induced Nitrosative Stress.Oral Contraceptive Use and Prevalence of Self-Reported Glaucoma or Ocular Hypertension in the United States.Is Estrogen a Therapeutic Target for Glaucoma?Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina.Gender difference in the pathophysiology and treatment of glaucoma.Biochemical changes and treatment in glaucoma.Present and New Treatment Strategies in the Management of Glaucoma.Targeting estrogen receptor β as preventive therapeutic strategy for Leber's hereditary optic neuropathy.Evaluating retinal ganglion cell loss and dysfunctionLeber hereditary optic neuropathy: bridging the translational gap.The impact of combined oral contraceptives on ocular tissues: a review of ocular effects.The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model.An exploratory investigation of brain-selective estrogen treatment in males using a mouse model of Alzheimer's disease.Impact of aromatase absence on murine intraocular pressure and retinal ganglion cells.Novel therapeutics in glaucoma management.The Association between Female Reproductive Factors and Open-Angle Glaucoma in Korean Women: The Korean National Health and Nutrition Examination Survey V
P2860
Q26775083-B692E721-8CAE-4BBB-9975-E43EC545E2ABQ29248820-B71F12C6-5BC1-443C-9463-429F40853907Q35736555-E6BD488C-BA25-470E-9D02-1BB4790308F6Q36005823-2B7FD060-03C9-467D-9D05-F4D4C86926CFQ36512655-C0308E8E-679B-4412-A158-38537819A322Q36871124-77ACCEA7-122B-431F-887A-9EB7B01EF8A8Q37059521-5AC13F7E-A317-4C74-95C9-5B1AA8DFE3AEQ37645117-2B3817B3-139C-4B11-9A26-2545A95CBDB1Q38257023-B91C1DEE-316D-4FAE-ADD1-92116B7D8C26Q38443580-24CD9D53-F062-413B-BEEC-6527A0C80C86Q38526185-41BC2511-A926-4567-8EB8-557F72E4943AQ38832079-E349E997-1ED8-449D-A4AA-23EE3148BE19Q38927439-22151F25-A808-4701-B6E8-0C58BC0F6C40Q39398632-93100CCA-D15F-4C7A-A1D1-59927D4043D0Q45399966-ECA9A157-0836-4BBB-BE01-1F8A386663D6Q47102063-00F6B6D5-5569-48E9-8B99-AE8BB58270C4Q47355534-896BCAF5-4388-449B-8CDB-2B76D24E3456Q49830306-5A9D2DD2-30C8-4789-AD32-F076CC85BDF1Q50023818-D7E0658C-2F6C-4B3C-9C24-16F9B15AE35EQ57215655-4598D255-8DE1-4BC1-B4F1-60F4957D34C8
P2860
17β-estradiol eye drops protect the retinal ganglion cell layer and preserve visual function in an in vivo model of glaucoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
17β-estradiol eye drops protec ...... an in vivo model of glaucoma.
@en
17β-estradiol eye drops protec ...... an in vivo model of glaucoma.
@nl
type
label
17β-estradiol eye drops protec ...... an in vivo model of glaucoma.
@en
17β-estradiol eye drops protec ...... an in vivo model of glaucoma.
@nl
prefLabel
17β-estradiol eye drops protec ...... an in vivo model of glaucoma.
@en
17β-estradiol eye drops protec ...... an in vivo model of glaucoma.
@nl
P2093
P2860
P356
P1476
17β-estradiol eye drops protec ...... n an in vivo model of glaucoma
@en
P2093
Balazs Blazics
Katalin Prokai-Tatrai
Peter Koulen
Szabolcs Szarka
Vien Nguyen
P2860
P304
P356
10.1021/MP400313U
P407
P577
2013-07-23T00:00:00Z